한글목차

세계 DTC(Direct-to-Consumer) 유전자 검사 시장 규모는 2024년 23억 달러에서 예측 기간 동안 10.0%의 연평균 복합 성장률(CAGR)을 나타내고, 2029년 말에는 37억 달러 규모로 성장할 것으로 예상됩니다.

조상 검사 부문은 2024년 16억 달러에서 연평균 9.2% 성장하여 2029년 말에는 24억 달러에 달할 것으로 예측됩니다. 건강 상태 검사 부문은 2024년 5억 1,680만 달러에서 연평균 12.9% 성장하여 2029년 말에는 9억 4,840만 달러에 달할 것으로 예측됩니다.

세계의 DTC(Direct-to-Consumer) 유전자 검사(DTC) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등의 정보를 전해드립니다. 시장 규모 추이, 지역별 상세 분석, 경쟁상황, 주요 기업 프로파일 등을 정리하였습니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 개요

제2장 시장 개요

• 시장 개요와 정의
• 유전자 검사
• DTC 유전자 검사의 역사
• DTC 유전자 검사의 유형
• 규제 프레임워크
• 미국
• 유럽
• 아시아태평양

제3장 시장 역학

• 시장 역학
• 시장 성장 촉진요인
• 유전체 배열 분석의 비용 절감
• 적극적인 마케팅
• 약물유전체학 검사
• 만성질환 증가
• 의식 향상
• 시장 기회
• 환자와 의사의 제휴 강화
• 시장 성장 억제요인
• DTC 유전자 검사의 비효율성
• 한정적인 보험 적용
• 프라이버시에 관한 우려
• 잘못된 결과
• 소개 증가에 드는 비용
• 시장이 해결해야 할 과제
• 공급망 과제
• 데이터 관리, 품질 관리, 고객 서비스

제4장 신기술과 개발

• 개요
• AI
• WGS 및 WES
• 블록체인 기술
• 의약품 개발 유전체 데이터

제5장 DTC 유전자 검사 시장

• 세분화 내역
• 시장 내역 : 제품 유형별
• 조상 DTC 유전자 검사 시장
• 건강 상태 DTC 유전자 검사 시장
• 라이프스타일 DTC 유전자 검사 시장
• 지역별 분석
• 시장 내역 : 지역별
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 기타 지역

제6장 경쟁 정보

• 업계 시나리오
• 기업 점유율
• 경쟁 구도

제7장 DTC 유전자 검사 업계에서의 지속가능성 : ESG 관점

• ESG : 서론
• 환경 퍼포먼스
• 사회적 퍼포먼스
• 거버넌스 퍼포먼스
• BCC의 결론

제8장 특허 분석

제9장 부록

• 조사 방법
• 참고 문헌
• 약어
• 기업 개요
• 23ANDME INC.
• ANCESTRY
• COLOR HEALTH INC.
• DANTE LABS GLOBAL
• MYDNA LIFE AUSTRALIA PTY LTD.
• MYHERITAGE LTD.
• PRIVAPATH DIAGNOSTICS

영문목차

The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.

The ancestry segment of DTC genetic testing market is expected to grow from $1.6 billion in 2024 and is projected to reach $2.4 billion by the end of 2029, at a CAGR of 9.2% during the forecast period of 2024 to 2029.

The health segment of DTC genetic testing market is expected to grow from $516.8 million in 2024 and is projected to reach $948.4 million by the end of 2029, at a CAGR of 12.9% during the forecast period of 2024 to 2029.

Report scope

The report analyzes the market for DTC genetic testing, offering a look at the competitive landscape and the leading companies' revenues, product portfolios and recent developments. The report analyzes trends and market dynamics, including drivers, limitations, challenges and opportunities. It assesses current and potential market size, in order to help industry executives make informed decisions about the production and licensing of goods and services. The study segments the market on the basis of segment/application type, such as ancestry, health and lifestyle. The health market segment is analyzed by technology and by disease category (cancer, cardiovascular, complex common, pharmacogenomics, rare diseases and others). The lifestyle market segment is segmented by technology and application (genetic relatedness, nutrigenomics, personal traits, weight management/fitness and others).

Regional market analysis is provided for all the major segments. The report covers tests that are directly ordered by consumers and consumer-initiated, physician-monitored tests. The DTC genetic testing of animals is outside the scope of the report. Regional market analysis is provided for all the major segments, and this includes some country-level analysis.

This report reviews the main DTC genetic testing technologies, including next-generation sequencing (NGS) and genotyping microarrays.

In this report, the market is divided into the following segments:

Market applications:

• Ancestry.
• Health.
• Lifestyle.

Technologies:

• Genotyping arrays.
• Whole genome sequencing (WGS).
• Whole exome sequencing (WES).
• Polymerase chain reaction (PCR).
• Targeted sequencing.

For each segment, current products are identified for the base year of 2023, the current market size is measured and market drivers identified, forecasts are made for 2029, and the current market shares of companies are assessed.

Report Includes

• 18 data tables and 27 additional tables
• An overview of the global market and technologies for Direct-to-Consumer Genetic Testing
• Analyses of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
• Evaluation of the current market size and prospects for revenue growth, accompanied by a market share analysis by product type, and region
• Forecast of future trends, including regulatory challenges, review of patents, ESG trends and emerging technologies
• Market share analysis of the key companies in the industry and coverage of mergers & acquisitions, joint ventures, collaborations, partnerships and other strategies
• Profiles of the major players, including Ancestry, 23andMe, MyHeritage, myDNA, Dante Labs, and Color Health

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Market Overview and Definitions
• Genetic Testing
• History of DTC Genetic Testing
• Types of DTC Genetic Tests
• Regulatory Framework
• United States
• Europe
• Asia-Pacific

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Dropping Cost of Genomic Sequencing
• Aggressive Marketing
• Pharmacogenomic Testing
• Increasing Prevalence of Chronic Diseases
• Increasing Awareness
• Market Opportunities
• Enhancing Patient-Physician Collaboration
• Market Restraints
• Inefficiencies of DTC Genetic Tests
• Limited Insurance Coverage
• Privacy Concerns
• False Results
• Costs of Increased Referrals
• Market Challenges
• Supply Chain Challenges
• Data Management, Quality Control and Customer Service

Chapter 4 Emerging Technologies and Developments

• Overview
• Artificial Intelligence
• WGS and WES
• Blockchain Technology
• Genomic Data in Drug Development

Chapter 5 DTC Genetic Testing Market

• Segmentation Breakdown
• Market Breakdown, by Product Type
• Ancestry DTC Genetic Testing Market
• Health DTC Genetic Testing Market
• Lifestyle DTC Genetic Testing Market
• Geographic Breakdown
• Market Breakdown, by Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Rest of the World

Chapter 6 Competitive Intelligence

• Industry Scenario
• Company Shares
• Competitive Landscape

Chapter 7 Sustainability in the DTC Genetic Testing Industry: An ESG Perspective

• Introduction to ESG
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Patent Analysis

Chapter 9 Appendix

• Research Methodology
• References
• Abbreviations
• Company Profiles
• 23ANDME INC.
• ANCESTRY
• COLOR HEALTH INC.
• DANTE LABS GLOBAL
• MYDNA LIFE AUSTRALIA PTY LTD.
• MYHERITAGE LTD.
• PRIVAPATH DIAGNOSTICS